Skip to menu Skip to content Skip to footer

Evaluation of Tolebrutinib as a novel disease-modifying therapeutic for Parkinson's disease (2022-2024)

Experts

Dr Richard Gordon

Honorary Associate Professor
UQ Centre for Clinical Research
Faculty of Medicine
Richard Gordon
Richard Gordon

Associate Professor John O'Sullivan

ATH - Associate Professor
UQ Centre for Clinical Research
Faculty of Medicine
John O'Sullivan
John O'Sullivan

Dr Rob Adam

Trials Medical Specialist
UQ Centre for Clinical Research
Faculty of Medicine
Rob Adam
Rob Adam